Cookson Peirce & CO Inc Tg Therapeutics, Inc. Transaction History
Cookson Peirce & CO Inc
- $1.86 Billion
- Q1 2025
A detailed history of Cookson Peirce & CO Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Cookson Peirce & CO Inc holds 32,742 shares of TGTX stock, worth $1.18 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
32,742
Previous 28,081
16.6%
Holding current value
$1.18 Million
Previous $845,000
52.78%
% of portfolio
0.07%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding TGTX
# of Institutions
416Shares Held
88.1MCall Options Held
2.34MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA15.6MShares$562 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$410 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$268 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$118 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$103 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.23B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...